A citation-based method for searching scientific literature

Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
Times Cited: 10







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
40
40

Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
21
40

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
30


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
30

Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
31
30

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
198
30


Pleiotropic, heart rate-independent cardioprotection by ivabradine.
P Kleinbongard, N Gedik, P Witting, B Freedman, N Klöcker, G Heusch. Br J Pharmacol 2015
51
20

Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia.
F Maranta, L Tondi, E Agricola, A Margonato, O Rimoldi, Paolo G Camici. Basic Res Cardiol 2015
12
20

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
339
20

Coronary microvascular dysfunction: an update.
Filippo Crea, Paolo G Camici, Cathleen Noel Bairey Merz. Eur Heart J 2014
368
20

Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Xavier Monnet, Patrice Colin, Bijan Ghaleh, Luc Hittinger, Jean-François Giudicelli, Alain Berdeaux. Eur Heart J 2004
53
20

Coronary microvascular dysfunction: mechanisms and functional assessment.
Paolo G Camici, Giulia d'Amati, Ornella Rimoldi. Nat Rev Cardiol 2015
228
20

Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
139
20

Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
Gerd Heusch, Andreas Skyschally, Petra Gres, Patrick van Caster, Dustin Schilawa, Rainer Schulz. Eur Heart J 2008
112
20

Optimal medical therapy with or without PCI for stable coronary disease.
William E Boden, Robert A O'Rourke, Koon K Teo, Pamela M Hartigan, David J Maron, William J Kostuk, Merril Knudtson, Marcin Dada, Paul Casperson, Crystal L Harris,[...]. N Engl J Med 2007
20

Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.
Stephan H Schirmer, Achim Degen, Magnus Baumhäkel, Florian Custodis, Lisa Schuh, Michael Kohlhaas, Erik Friedrich, Ferdinand Bahlmann, Reinhard Kappl, Christoph Maack,[...]. Eur Heart J 2012
53
20

alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans.
G Heusch, D Baumgart, P Camici, W Chilian, L Gregorini, O Hess, C Indolfi, O Rimoldi. Circulation 2000
182
20


Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
539
20

Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy.
Michal Tendera, Olivier Chassany, Roberto Ferrari, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Kim Fox. Circ Cardiovasc Qual Outcomes 2016
11
20

Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
285
20

Exploring HCN channels as novel drug targets.
Otilia Postea, Martin Biel. Nat Rev Drug Discov 2011
140
20

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.
Joseph Yeboah, Aaron R Folsom, Gregory L Burke, Craig Johnson, Joseph F Polak, Wendy Post, Joao A Lima, John R Crouse, David M Herrington. Circulation 2009
638
20

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. J Am Coll Cardiol 2017
20


Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
50
20

The role of nitric oxide on endothelial function.
Dimitris Tousoulis, Anna-Maria Kampoli, Costas Tentolouris, Nikolaos Papageorgiou, Christodoulos Stefanadis. Curr Vasc Pharmacol 2012
460
20

The myocardial oxygen supply:demand index revisited.
Julien I E Hoffman, Gerald D Buckberg. J Am Heart Assoc 2014
67
10


The coronary collateral circulation: genetic and environmental determinants in experimental models and humans.
Paul F A Teunissen, Anton J G Horrevoets, Niels van Royen. J Mol Cell Cardiol 2012
27
10


Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice.
A Drouin, M-E Gendron, E Thorin, M-A Gillis, F Mahlberg-Gaudin, J-C Tardif. Br J Pharmacol 2008
74
10

Experimental subendocardial ischemia in dogs with normal coronary arteries.
G D Buckberg, D E Fixler, J P Archie, J I Hoffman. Circ Res 1972
855
10


Myocardial hibernation: a delicate balance.
Gerd Heusch, Rainer Schulz, Shahbudin H Rahimtoola. Am J Physiol Heart Circ Physiol 2005
146
10

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Carl J Pepine, Eileen M Handberg, Rhonda M Cooper-DeHoff, Ronald G Marks, Peter Kowey, Franz H Messerli, Giuseppe Mancia, José L Cangiano, David Garcia-Barreto, Matyas Keltai,[...]. JAMA 2003
871
10



Ivabradine improves coronary flow reserve in patients with stable coronary artery disease.
Emmanouil I Skalidis, Michalis I Hamilos, Gregory Chlouverakis, Evangelos A Zacharis, Panos E Vardas. Atherosclerosis 2011
35
10


Hibernating myocardium.
W Wijns, S F Vatner, P G Camici. N Engl J Med 1998
338
10

Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries.
D Baumgart, M Haude, G Görge, F Liu, J Ge, C Grosse-Eggebrecht, R Erbel, G Heusch. Circulation 1999
118
10

Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise.
R Seitelberger, B D Guth, G Heusch, J D Lee, K Katayama, J Ross. Circ Res 1988
127
10


Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen.
Eduard I Dedkov, Wei Zheng, Lance P Christensen, Robert M Weiss, Florence Mahlberg-Gaudin, Robert J Tomanek. Am J Physiol Heart Circ Physiol 2007
58
10

Bradycardia stimulates vascular growth during gradual coronary occlusion.
Kathryn G Lamping, Wei Zheng, Dezhi Xing, Lance P Christensen, James Martins, Robert J Tomanek. Arterioscler Thromb Vasc Biol 2005
26
10

Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements.
Pascal Meier, Steffen Gloekler, Rainer Zbinden, Sarah Beckh, Stefano F de Marchi, Stephan Zbinden, Kerstin Wustmann, Michael Billinger, Rolf Vogel, Stéphane Cook,[...]. Circulation 2007
232
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.